Joseph Schwartz
Stock Analyst at Leerink Partners
(4.95)
# 142
Out of 5,044 analysts
1274
Total ratings
53.4%
Success rate
32.2%
Average return
Main Sectors:
Stocks Rated by Joseph Schwartz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $28.53 | $10.71 | +166.40% | 2 | Oct 1, 2026 | |
| QNCX Quince Therapeutics | Reiterated: Buy | $80 → $68 | $31.73 | +114.31% | 2 | Sep 29, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $154 | $86.01 | +79.05% | 1 | Sep 28, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | n/a | $39.06 | - | 51 | Sep 23, 2026 | |
| ELOX Eloxx Pharmaceuticals | Initiated Coverage: Buy | $32 | $13.74 | +132.90% | 1 | Sep 18, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $33 | $15.48 | +113.18% | 71 | Sep 18, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $20 | $6.87 | +191.12% | 46 | Sep 16, 2026 | |
| PHVS Pharvaris | Rated: Buy | $38 → $65 | $31.10 | +109.00% | 38 | Sep 10, 2026 | |
| GOSS Gossamer Bio | Upgraded: Buy | $80 | $9.31 | +759.29% | 36 | Jul 27, 2026 | |
| QURE uniQure | Reiterated: Buy | $60 → $70 | $22.59 | +209.87% | 62 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $305 | $229.23 | +33.05% | 72 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $24 → $4 | $3.77 | +6.10% | 37 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 → $62 | $54.80 | +13.15% | 90 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1 → $9 | $4.40 | +104.55% | 23 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $8.40 | +197.62% | 1 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $120 | $44.05 | +172.42% | 32 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $25 | $3.46 | +622.54% | 31 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $27.11 | +84.43% | 9 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $17.85 | -15.97% | 107 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $52.13 | - | 87 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.60 | - | 50 | Dec 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $2 | $0.3499 | +471.59% | 31 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $16 | $16.65 | -3.90% | 52 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5 → $14 | $11.65 | +20.17% | 29 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $115 | $78.96 | +45.64% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $54 | $64.70 | -16.54% | 33 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $100.60 | n/a | 63 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.67 | n/a | 22 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.62 | n/a | 29 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $1.10 | n/a | 29 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $2.41 | n/a | 19 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $301.79 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $150 → $30 | $7.06 | n/a | 10 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $34 | $45.28 | n/a | 3 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $143.73 | n/a | 28 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $414.87 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.48 | n/a | 1 | Jul 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $4 | $40.98 | n/a | 16 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $332.99 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54.00 | $218.17 | n/a | 1 | Apr 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $30 | $0.7601 | n/a | 2 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $37 → $23 | $13.07 | n/a | 2 | Nov 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $12 | $1.63 | n/a | 5 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $121 → $126 | $549.16 | n/a | 4 | Apr 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.80 | n/a | 11 | Nov 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.0551 | n/a | 5 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $2.71 | n/a | 6 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.38 | n/a | 1 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $664 | $746.54 | n/a | 7 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $512 → $425 | $225.71 | n/a | 3 | Sep 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 → $8 | $62.91 | n/a | 3 | May 19, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.03 | n/a | 6 | Oct 30, 2013 |
Satellos Bioscience Inc.
Oct 1, 2026
Reiterated: Buy
Price Target: $28.53
Current: $10.71
Upside: +166.40%
Quince Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $80 → $68
Current: $31.73
Upside: +114.31%
Mirum Pharmaceuticals
Sep 28, 2026
Reiterated: Buy
Price Target: $154
Current: $86.01
Upside: +79.05%
Edgewise Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $39.06
Upside: -
Eloxx Pharmaceuticals
Sep 18, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $13.74
Upside: +132.90%
Ultragenyx Pharmaceutical
Sep 18, 2026
Reiterated: Buy
Price Target: $33
Current: $15.48
Upside: +113.18%
Solid Biosciences
Sep 16, 2026
Reiterated: Buy
Price Target: $20
Current: $6.87
Upside: +191.12%
Pharvaris
Sep 10, 2026
Rated: Buy
Price Target: $38 → $65
Current: $31.10
Upside: +109.00%
Gossamer Bio
Jul 27, 2026
Upgraded: Buy
Price Target: $80
Current: $9.31
Upside: +759.29%
uniQure
Jun 17, 2026
Reiterated: Buy
Price Target: $60 → $70
Current: $22.59
Upside: +209.87%
Jun 2, 2026
Reiterated: Buy
Price Target: $225 → $305
Current: $229.23
Upside: +33.05%
Jun 2, 2026
Downgraded: Hold
Price Target: $24 → $4
Current: $3.77
Upside: +6.10%
May 18, 2026
Reiterated: Hold
Price Target: $60 → $62
Current: $54.80
Upside: +13.15%
May 15, 2026
Upgraded: Buy
Price Target: $1 → $9
Current: $4.40
Upside: +104.55%
May 15, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $8.40
Upside: +197.62%
May 15, 2026
Reiterated: Buy
Price Target: $160 → $120
Current: $44.05
Upside: +172.42%
Mar 26, 2026
Reiterated: Buy
Price Target: $26 → $25
Current: $3.46
Upside: +622.54%
Mar 25, 2026
Reiterated: Buy
Price Target: $50
Current: $27.11
Upside: +84.43%
Mar 25, 2026
Reiterated: Hold
Price Target: $15
Current: $17.85
Upside: -15.97%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $52.13
Upside: -
Dec 31, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.60
Upside: -
Dec 29, 2025
Reiterated: Buy
Price Target: $8 → $2
Current: $0.3499
Upside: +471.59%
Dec 3, 2025
Downgraded: Hold
Price Target: $12 → $16
Current: $16.65
Upside: -3.90%
Dec 3, 2025
Upgraded: Buy
Price Target: $5 → $14
Current: $11.65
Upside: +20.17%
Nov 10, 2025
Initiated Coverage: Buy
Price Target: $115
Current: $78.96
Upside: +45.64%
Oct 16, 2025
Reiterated: Hold
Price Target: $54
Current: $64.70
Upside: -16.54%
Sep 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $100.60
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $25
Current: $2.67
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $10
Current: $2.62
Upside: n/a
Aug 12, 2024
Reiterated: Hold
Price Target: $1
Current: $1.10
Upside: n/a
May 7, 2024
Reiterated: Hold
Price Target: $10
Current: $2.41
Upside: n/a
Sep 7, 2023
Reiterated: Hold
Price Target: $14
Current: $301.79
Upside: n/a
Aug 18, 2023
Downgraded: Hold
Price Target: $150 → $30
Current: $7.06
Upside: n/a
Feb 3, 2023
Reiterated: Hold
Price Target: $40 → $34
Current: $45.28
Upside: n/a
Aug 5, 2022
Reiterated: Buy
Price Target: $30
Current: $143.73
Upside: n/a
Aug 4, 2022
Rated: Hold
Price Target: n/a
Current: $414.87
Upside: n/a
Jul 13, 2022
Reiterated: Buy
Price Target: n/a
Current: $10.48
Upside: n/a
Apr 5, 2022
Downgraded: Hold
Price Target: $31 → $4
Current: $40.98
Upside: n/a
May 7, 2021
Downgraded: Sell
Price Target: n/a
Current: $332.99
Upside: n/a
Apr 15, 2021
Reiterated: Buy
Price Target: $54.00
Current: $218.17
Upside: n/a
Jan 6, 2021
Downgraded: Hold
Price Target: $5 → $30
Current: $0.7601
Upside: n/a
Nov 28, 2018
Initiated Coverage: Buy
Price Target: $37 → $23
Current: $13.07
Upside: n/a
Sep 26, 2017
Reiterated: Buy
Price Target: $10 → $12
Current: $1.63
Upside: n/a
Apr 3, 2017
Reiterated: Hold
Price Target: $121 → $126
Current: $549.16
Upside: n/a
Nov 13, 2016
Reiterated: Buy
Price Target: n/a
Current: $9.80
Upside: n/a
Nov 10, 2016
Reiterated: Buy
Price Target: $8
Current: $0.0551
Upside: n/a
Nov 10, 2016
Reiterated: Buy
Price Target: $12 → $14
Current: $2.71
Upside: n/a
Mar 8, 2016
Reiterated: Buy
Price Target: $24
Current: $1.38
Upside: n/a
Oct 26, 2015
Reiterated: Buy
Price Target: $664
Current: $746.54
Upside: n/a
Sep 15, 2015
Reiterated: Buy
Price Target: $512 → $425
Current: $225.71
Upside: n/a
May 19, 2014
Initiated Coverage: Buy
Price Target: $20 → $8
Current: $62.91
Upside: n/a
Oct 30, 2013
Downgraded: Hold
Price Target: n/a
Current: $12.03
Upside: n/a